MORE►
biotech startup
Left: Daniel Hargrove, co-founder and CEO of InterAct Therapeutics; Right: Isaac Chan, MD, PhD, Co-founder and CSO of InterAct Therapeutics [Photos: LinkedIn]
UTSW Spinout InterAct Therapeutics Selected by Cell & Gene Therapy Incubator Program
by Sandra Engelland | Dec 11, 2025
InterAct, which launched inside BioLabs at Pegasus Park, is a preclinical stage biotech company developing AAV8-based gene therapies for metastatic cancer, with an initial focus on breast cancer-derived liver metastases.
by Lauren Hawkins |
Dec 8, 2020
Dallas life science startups are invited to apply to ThinkLab's winter cohort, which will begin in late January 2021.
MORE►
by David Kirkpatrick |
Mar 13, 2020
Exact Diagnostics, which develops and manufactures products to ensure test result validity, will now help more laboratories keep pace with the increasing demand for COVID-19 testing.
MORE►
by Nicholas Sakelaris |
Nov 14, 2017
The Fort Worth biotech startup developed a topical treatment that dissolves earwax, the first over-the-counter product of its kind.
MORE►
